Research on the Development and Implementation of an Exercise Rehabilitation Program for Aortic Dissection Patients After Percutaneous Intervention Based on the Behavior Change Wheel Theory
1 other identifier
interventional
80
1 country
1
Brief Summary
Study Title : Effectiveness of a BCW Theory-Based Exercise Rehabilitation Program in Post-Endovascular Aortic Dissection Patients: A Randomized Controlled Trial Primary Objective : To determine whether an exercise rehabilitation program constructed based on the Behavior Change Wheel (BCW) framework improves postoperative quality of life (QoL) in patients undergoing endovascular aortic repair (EVAR). Methodology : Intervention Group (n= 40): Receives the BCW-based exercise rehabilitation protocol. Control Group (n= 40): Receives routine care and health education . Outcome Measures : Primary Endpoint :QoL changes assessed via validated scales ( SF-36) at: Pre-discharge (T0) 1 month postoperatively (T1) 3 months postoperatively (T2) Secondary Endpoints (Daily Monitoring): Exercise duration (minutes/day) Exercise intensity Post-exercise blood pressure (mmHg) Post-exercise heart rate (bpm)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 5, 2025
CompletedFirst Posted
Study publicly available on registry
August 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedAugust 12, 2025
August 1, 2025
6 months
August 5, 2025
August 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
SF-36
Preoperative,1 month postoperative,3 month postoperative
Secondary Outcomes (5)
HADS
Preoperative,1 month postoperative,3 month postoperative
PISQ
Preoperative,1 month postoperative,3 month postoperative
Self-Efficacy for Exercise Scale
Preoperative,1 month postoperative,3 month postoperative
complications
Within 3 months postoperatively
6MWT
Predischarge ,1 month postoperative,3 month postoperative
Study Arms (2)
BCW Rehabilitation
EXPERIMENTALRoutine Care
ACTIVE COMPARATORInterventions
Inpatient Care: Continuously monitor vital signs (BP, HR, SpO₂), neurological status, and limb function; administer prescribed antihypertensives with thorough medication education and efficacy tracking. Strictly prohibit Valsalva maneuvers . Assess pain levels, wounds, and psychological state; deliver scheduled analgesics and emotional counseling to maintain stable mood. Implement lifestyle optimization: 7+hr sleep/night, portion-controlled nutrition, and gradual postoperative mobilization. Discharge \& Follow-up: Enforce BP control through medication adherence. Ban vigorous activities (mountaineering/swimming/competitive sports); allow low-stress aerobics . Distribute Exercise Diaries (Appx 6) mandating daily logs with critical warnings: STOP immediately if nausea, chest pressure, dizziness, dyspnea, or arrhythmia occur and urgent revisit. Require complete tobacco cessation and secondhand smoke avoidance.
1.1 Assessment of physical fitness and formulation of individualized exercise rehabilitation plans 1.2 Inpatient Phase (Postoperative Day 1 - Week 1): Monitor via ICU Mobility Scale (IMS) before each session:▪ Score 0 : Passive range of motion (PROM) exercises▪ Scores 1-3 : Active bed-based joint mobility training▪ Scores 4-6 : Standing balance training▪ Scores 7-10 : Ambulatory walking training 1.3 Early Outpatient Phase (Weeks 2-4): Initiate when IMS=10:▪ Perform 6-Minute Walk Test (6MWT) ▪ If distance \>450m: Prescribe low-intensity aerobic walking " Speed: 3 km/h" Progression: Start at 10 min/day (≈500 steps), increase by 10 min every other day up to 40 min/day 1.4 Intermediate Rehabilitation (Weeks 5-12): Moderate-intensity aerobic walking + Resistance training :▪ Walking: 4-6 km/h, 30 min/session, 3 sessions/week▪ Resistance training: Seated elastic band exercises, 20 min/session, 2 sessions/week
Eligibility Criteria
You may qualify if:
- Patients with confirmed aortic dissection diagnosis by CTA and MRI, undergoing endovascular interventions : Thoracic Endovascular Aortic Repair (TEVAR), fenestrated endografting, or branched stent-graft techniques.
- Conscious and capable of voluntary participation in this study (with documented informed consent).
You may not qualify if:
- Severe concomitant organ diseases, such as coronary artery disease (CAD) , valvular heart disease , ventricular aneurysm , or life-threatening arrhythmias .
- Patients with unstable angina or myocardial infarction within the past 1 month .
- Patients with comorbid psychiatric disorders.
- Patients with active infections or malignant tumors.
- Presence of pacemakers or implantable cardioverter-defibrillators (ICDs) .
- Translation : Hemodynamic instability with thrombosis , malperfusion , or coagulopathies.
- Concurrent participation in other clinical trials .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shuzhen Wanglead
Study Sites (1)
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330008, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Nurse Practitioner (NP)
Study Record Dates
First Submitted
August 5, 2025
First Posted
August 12, 2025
Study Start
July 1, 2025
Primary Completion
December 31, 2025
Study Completion
February 28, 2026
Last Updated
August 12, 2025
Record last verified: 2025-08